|
16-8-2021 8:21 EDT
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
11-8-2021 1:30 EDT
| Six-month interim report (Q2) 2021 |
|
9-8-2021 9:34 EDT
| ALK upgrades its full-year financial outlook |
|
5-8-2021 4:24 EDT
| Change to ALK’s Board of Directors |
|
5-8-2021 2:32 EDT
| Release date of six-month interim report (Q2) 2021 for ALK and audio cast |
|
30-7-2021 8:51 EDT
| ALK and Grandpharma team up to market the first adrenaline autoinjector in China |
|
10-5-2021 11:25 EDT
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
5-5-2021 0:57 EDT
| Three-month interim report (Q1) 2021 |
|
28-4-2021 3:09 EDT
| Release date of three-month interim report (Q1) 2021 for ALK and audio cast |
|
26-3-2021 8:00 EDT
| Grant of share options and performance shares to members of the Board of Management and key employees |
|
18-3-2021 12:42 EDT
| Annual General Meeting in ALK-Abelló A/S held on 18 March 2021 |
|
10-3-2021 11:05 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
3-3-2021 11:06 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
2-3-2021 13:54 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
2-3-2021 13:50 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
24-2-2021 11:01 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
23-2-2021 8:00 EST
| Annual General Meeting in ALK-Abelló A/S on 18 March 2021 |
|
19-2-2021 11:29 EST
| Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff |
|
10-2-2021 1:30 EST
| ALK releases 2020 annual report |
|
4-2-2021 5:35 EST
| Release date of annual report 2020 for ALK and audio cast |
